These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 1103617)
21. Use of heparin to lower the incidence of phlebitis induced by anti-neoplastic agents used in ovarian cancer. Ikeda S; Douchi T; Nagata Y J Obstet Gynaecol Res; 2004 Dec; 30(6):427-9. PubMed ID: 15566456 [TBL] [Abstract][Full Text] [Related]
22. Relationship between incidence of phlebitis and frequency of changing IV tubing and percutaneous site. Nichols EG; Barstow RE; Cooper D Nurs Res; 1983; 32(4):247-52. PubMed ID: 6553250 [TBL] [Abstract][Full Text] [Related]
23. Heparin sodium versus 0.9% sodium chloride injection for maintaining patency of indwelling intermittent infusion devices. Hamilton RA; Plis JM; Clay C; Sylvan L Clin Pharm; 1988 Jun; 7(6):439-43. PubMed ID: 3402178 [TBL] [Abstract][Full Text] [Related]
24. Double-blind comparison of phlebitis associated with cefazolin and cephalothin. Cole DR Int J Clin Pharmacol Biopharm; 1976 Jul; 14(1):75-7. PubMed ID: 789268 [TBL] [Abstract][Full Text] [Related]
33. Sepsis in rabbits following administration of contaminated infusions through filters of various pore sizes. Rapp RP; Bivins BA; DeLuca P Am J Hosp Pharm; 1979 Dec; 36(12):1711-3. PubMed ID: 525650 [TBL] [Abstract][Full Text] [Related]
35. The influence of heparin on intravenous infusions: a prospective study. Tanner WA; Delaney PV; Hennessy TP Br J Surg; 1980 May; 67(5):311-2. PubMed ID: 7388323 [TBL] [Abstract][Full Text] [Related]
36. [Particles in infusion fluids. Preventive effectiveness of terminal filters. Comparative study]. Arosio G; Vigasio F; Vegna AM; Lanza G; Corsini M; Rastrelli GF Minerva Anestesiol; 1981 Apr; 47(4):155-68. PubMed ID: 7242964 [TBL] [Abstract][Full Text] [Related]
37. Infusion phlebitis in medical and surgical patients in Siriraj Hospital. Danchaivijitr S; Srihapol N; Pakaworawuth S J Med Assoc Thai; 1995 Jul; 78 Suppl 2():S91-4. PubMed ID: 7561603 [TBL] [Abstract][Full Text] [Related]
38. [Risk factors for the development of phlebitis in peripheral infusions]. Klaver NS; Hermans J; Ulrich C Ned Tijdschr Geneeskd; 1998 Feb; 142(8):405-9. PubMed ID: 9562775 [TBL] [Abstract][Full Text] [Related]
39. Effect of filtering amphotericin B infusions on the incidence and severity of phlebitis and selected adverse reactions. Gotz VP; Rand KH; Kramer BS Drug Intell Clin Pharm; 1985 Jun; 19(6):436-9. PubMed ID: 3891285 [TBL] [Abstract][Full Text] [Related]
40. Predisposing factors to phlebitis in patients with peripheral intravenous catheters: a descriptive study. Uslusoy E; Mete S J Am Acad Nurse Pract; 2008 Apr; 20(4):172-80. PubMed ID: 18387013 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]